Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Aesthetic Plastic Surgery
Published in: Aesthetic Plastic Surgery 6/2021

01-12-2021 | Breast Augmentation | Review

Hematoma After Non-Oncologic Breast Procedures: A Comprehensive Review of the Evidence

Authors: David A. Daar, Jonathan M. Bekisz, Michael V. Chiodo, Evellyn M. DeMitchell-Rodriguez, Pierre B. Saadeh

Published in: Aesthetic Plastic Surgery | Issue 6/2021

Login to get access

Abstract

Background

Hematoma after non-oncologic breast surgery is a common concern requiring expeditious treatment. The purpose of this study is to perform an evidence-based review of perioperative factors that may contribute to hematoma in non-oncologic breast procedures.

Methods

A comprehensive literature review was performed of non-oncologic breast procedures: breast augmentation, single-stage augmentation-mastopexy, mastopexy, and reduction. In total, 28 studies highlighting incidence and potential risk factors for hematoma were included; overall level of evidence was established regarding each perioperative factor examined and hematoma rate.

Results

The hematoma rate in breast augmentation ranges from 0.2 to 5.7%. There is inconclusive evidence to support an association between pocket choice or incision location and hematoma rate (Level III) and no evidence of an association between implant type and hematoma (Level V). Single-stage augmentation-mastopexy may have a lower hematoma rate than augmentation alone (Level II). Hematoma may increase the risk of capsular contracture (Level III). In breast reduction, the hematoma rate ranges from 1.0 to 9.3%. Evidence of an association between incision choice and hematoma rate is inconclusive (Level III). Use of epinephrine-containing solution, pedicle choice, and resection weight do not appear to affect hematoma rate (Level V, II, and II, respectively). The use of postoperative drains and ketorolac do not affect the incidence of hematoma (Level I and III, respectively). Intraoperative hypotension may increase the risk of hematoma after breast reduction (Level III).

Conclusions

Breast hematomas are not uncommon complications. Current literature lacks ample evidence for risk factors for hematoma after non-oncologic breast procedures, warranting further, high-powered investigations.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
Society TA (2020) ASAPS Quick Facts: Highlights of the 2019 Stats
2.
Surgeons ASoP (2019). 2019 Plastic Surgery Statistics Report
3.
Kaoutzanis C, Winocour J, Gupta V, Ganesh Kumar N, Sarosiek K, Wormer B et al (2017) Incidence and risk factors for major hematomas in aesthetic surgery: analysis of 129,007 patients. Aesthet Surg J 37(10):1175–1185PubMed
4.
Sullivan D, Chung KC, Eaves FF 3rd, Rohrich RJ (2011) The level of evidence pyramid: indicating levels of evidence in plastic and reconstructive surgery articles. Plast Reconstr Surg 128(1):311–314PubMed
5.
Diaz JF (2017) Review of 494 consecutive breast augmentation patients: system to improve patient outcomes and satisfaction. Plast Reconstr Surg Glob Open 5(10):e1526PubMedPubMedCentral
6.
Somogyi RB, Brown MH (2015) Outcomes in primary breast augmentation: a single surgeon’s review of 1539 consecutive cases. Plast Reconstr Surg 135(1):87–97PubMed
7.
Tebbetts JB (2006) Axillary endoscopic breast augmentation: processes derived from a 28-year experience to optimize outcomes. Plast Reconstr Surg 118(7):53S-80SPubMed
8.
Gabriel SE, Woods JE, O’Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd (1997) Complications leading to surgery after breast implantation. N Engl J Med 336(10):677–682PubMed
9.
Alderman AK, Collins ED, Streu R, Grotting JC, Sulkin AL, Neligan P et al (2009) Benchmarking outcomes in plastic surgery: national complication rates for abdominoplasty and breast augmentation. Plast Reconstr Surg 124(6):2127–2133PubMed
10.
Khan UD (2013) Muscle-splitting, subglandular, and partial submuscular augmentation mammoplasties: a 12-year retrospective analysis of 2026 primary cases. Aesthet Plast Surg 37(2):290–302
11.
Stutman RL, Codner M, Mahoney A, Amei A (2012) Comparison of breast augmentation incisions and common complications. Aesthet Plast Surg 36(5):1096–1104
12.
Jacobson JM, Gatti ME, Schaffner AD, Hill LM, Spear SL (2012) Effect of incision choice on outcomes in primary breast augmentation. Aesthet Surg J. 32(4):456–462PubMed
13.
Swanson E (2013) Prospective comparative clinical evaluation of 784 consecutive cases of breast augmentation and vertical mammaplasty, performed individually and in combination. Plast Reconstr Surg 132(1):30e–45ePubMed
14.
Khavanin N, Jordan SW, Rambachan A, Kim JY (2014) A systematic review of single-stage augmentation-mastopexy. Plast Reconstr Surg 134(5):922–931PubMed
15.
Kerrigan CL, Slezak SS (2013) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 132(6):1670–1683PubMed
16.
Nguyen BN, Barta RJ, Stewart CE, Heinrich CA (2018) Toradol following breast surgery: is there an increased risk of hematoma? Plast Reconstr Surg 141(6):814e-e817PubMed
17.
Firriolo JM, Nuzzi LC, Schmidtberg LC, Labow BI (2018) Perioperative ketorolac use and postoperative hematoma formation in reduction mammaplasty: a single-surgeon experience of 500 consecutive cases. Plast Reconstr Surg 142(5):632e-e638PubMed
18.
Barkho JO, Li YK, Duku E, Thoma A (2018) Ketorolac may increase hematoma risk in reduction mammaplasty: a case-control study. Plast Reconstr Surg Glob Open 6(3):e1699PubMedPubMedCentral
19.
Fernandez S, Coady L, Cohen-Shohet R, Molas-Pierson J, Mast BA (2016) Comparative outcomes and quality analysis of inverted-T and pure vertical scar techniques in superomedial pedicle reduction mammaplasty. Ann Plast Surg 76(4):S328–S331PubMed
20.
Ogunleye AA, Leroux O, Morrison N, Preminger AB (2017) Complications after reduction mammaplasty: a comparison of wise pattern/inferior pedicle and vertical scar/superomedial pedicle. Ann Plast Surg 79(1):13–16PubMed
21.
Zoumaras J, Lawrence J (2008) Inverted-T versus vertical scar breast reduction: one surgeons 5-year experience with consecutive patients. Aesthet Surg J 28(5):521–526 ((discussion 6-7))PubMed
22.
Greco R, Noone B (2017) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 139(1):230e-e239PubMed
23.
Cruz-Korchin N, Korchin L (2003) Vertical versus wise pattern breast reduction: patient satisfaction, revision rates, and complications. Plast Reconstr Surg 112(6):1573–1578 ((d iscussion 9–81))PubMed
24.
Wrye SW, Banducci DR, Mackay D, Graham WP, Hall WW (2003) Routine drainage is not required in reduction mammaplasty. Plast Reconstr Surg 111(1):113–117PubMed
25.
Collis N, McGuiness CM, Batchelor AG (2005) Drainage in breast reduction surgery: a prospective randomised intra-patient trail. Br J Plast Surg 58(3):286–289PubMed
26.
Corion LU, Smeulders MJ, van Zuijlen PP, van der Horst CM (2009) Draining after breast reduction: a randomised controlled inter-patient study. J Plast Reconstr Aesthet Surg 62(7):865–868PubMed
27.
Srinivasaiah N, Iwuchukwu OC, Stanley PR, Hart NB, Platt AJ, Drew PJ (2014) Risk factors for complications following breast reduction: results from a randomized control trial. Breast J 20(3):274–278PubMed
28.
Cunningham BL, Gear AJ, Kerrigan CL, Collins ED (2005) Analysis of breast reduction complications derived from the BRAVO study. Plast Reconstr Surg 115(6):1597–1604PubMed
29.
Spector JA, Singh SP, Karp NS (2008) Outcomes after breast reduction: does size really matter? Ann Plast Surg 60(5):505–509PubMed
30.
Lapid O, Pietersen L, van der Horst CM (2012) Reoperation for haematoma after breast reduction with preoperative administration of low-molecular-weight heparin: experience in 720 patients. J Plast Reconstr Aesthet Surg 65(11):1513–1517PubMed
31.
Collins JB, Verheyden CN (2012) Incidence of breast hematoma after placement of breast prostheses. Plast Reconstr Surg 129(3):413e-e420PubMed
32.
Gupta V, Yeslev M, Winocour J, Bamba R, Rodriguez-Feo C, Grotting JC et al (2017) Aesthetic breast surgery and concomitant procedures: incidence and risk factors for major complications in 73,608 cases. Aesthet Surg J 37(5):515–527PubMed
33.
Stevens WG, Macias LH, Spring M, Stoker DA, Chacon CO, Eberlin SA (2014) One-stage augmentation mastopexy: a review of 1192 simultaneous breast augmentation and mastopexy procedures in 615 consecutive patients. Aesthet Surg J 34(5):723–732PubMed
34.
Hubbard TJ (2019) Vertical augmentation mastopexy with implant isolation and tension management. Plast Reconstr Surg Glob Open 7(6):e2226PubMedPubMedCentral
35.
Artz JD, Tessler O, Clark S, Patel S, Torabi R, Moses M (2019) Can it be safe and aesthetic? an eight-year retrospective review of mastopexy with concurrent breast augmentation. Plast Reconstr Surg Glob Open 7(6):e2272PubMedPubMedCentral
36.
Calobrace MB, Stevens WG, Capizzi PJ, Cohen R, Godinez T, Beckstrand M (2018) Risk factor analysis for capsular contracture: a 10-year sientra study using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg 141:20S–8SPubMed
37.
Codner MA, Mejia JD, Locke MB, Mahoney A, Thiels C, Nahai FR et al (2011) A 15-year experience with primary breast augmentation. Plast Reconstr Surg. 127(3):1300–1310PubMed
38.
Hidalgo DA, Weinstein AL (2020) Surgical treatment for capsular contracture: a new paradigm and algorithm. Plast Reconstr Surg 146(3):516–525PubMed
39.
Rancati A, Irigo M, Angrigiani C (2016) Management of the ischemic nipple-areola complex after breast reduction. Clin Plast Surg 43(2):403–414PubMed
40.
Ramanadham SR, Costa CR, Narasimhan K, Coleman JE, Rohrich RJ (2015) Refining the anesthesia management of the face-lift patient: lessons learned from 1089 consecutive face lifts. Plast Reconstr Surg 135(3):723–730PubMed
41.
Ramanadham SR, Mapula S, Costa C, Narasimhan K, Coleman JE, Rohrich RJ (2015) Evolution of hypertension management in face lifting in 1089 patients: optimizing safety and outcomes. Plast Reconstr Surg 135(4):1037–1043PubMed
42.
Auersvald A, Auersvald LA (2014) Hemostatic net in rhytidoplasty: an efficient and safe method for preventing hematoma in 405 consecutive patients. Aesthetic Plast Surg 38(1):1–9PubMed
43.
Ballan A, Jabbour S, El Rayess Y, Jabbour K, El Hachem L, Nasr M (2020) Quilting sutures in rhytidectomy: a systematic review of the literature. Aesthet Surg J 40(11):1157–1164PubMed
44.
45.
46.
Ausen K, Fossmark R, Spigset O, Pleym H (2015) Randomized clinical trial of topical tranexamic acid after reduction mammoplasty. Br J Surg 102(11):1348–1353PubMedPubMedCentral
47.
Ausen K, Hagen AI, Ostbyhaug HS, Olafsson S, Kvalsund BJ, Spigset O et al (2020) Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial. BJS Open 4(2):216–224PubMed
48.
Weissler JM, Banuelos J, Jacobson SR, Manrique OJ, Nguyen MT, Harless CA et al (2020) Intravenous tranexamic acid in implant-based breast reconstruction safely reduces hematoma without thromboembolic events. Plast Reconstr Surg 146(2):238–245PubMed
49.
Henry SL, Crawford JL, Puckett CL (2009) Risk factors and complications in reduction mammaplasty: novel associations and preoperative assessment. Plast Reconstr Surg 124(4):1040–1046PubMed
50.
Hussien M, Lee S, Malyon A, Norrie J, Webster M (2001) The impact of intraoperative hypotension on the development of wound haematoma after breast reduction. Br J Plast Surg 54(6):517–522PubMed
51.
Pedron M (2005) Minimal-scar breast reduction and mastopexy. Aesthetic Plast Surg 29(4):261–273PubMed
Metadata
Title
Hematoma After Non-Oncologic Breast Procedures: A Comprehensive Review of the Evidence
Authors
David A. Daar
Jonathan M. Bekisz
Michael V. Chiodo
Evellyn M. DeMitchell-Rodriguez
Pierre B. Saadeh
Publication date
01-12-2021

Other articles of this Issue 6/2021

Aesthetic Plastic Surgery 6/2021 Go to the issue

Letter to the Editor

Touch-ups, Rejuvenation, Re-dos and Revisions: Remote Communication and Cosmetic Surgery on the Rise

Original Article

Objective Comparison of FDA-Approved Breast Implant Products in the USA: 5-Year Update

Original Article

Oral Commissure Lift: A Retrospective Analysis of Complication Rates and Overall Outcomes

Editor’s Invited Commentary

Invited Discussion on: The Influence of Low and High Negative Pressure Liposuction and Different Harvesting Sites on the Viability and Yield of Adipocytes and Other Nucleated Cells—Does Pressure Matter? Swapping the Paradigm with Comparative Facts

Original Article

Factors Affecting Patient Satisfaction in Breast Reduction Surgeries: A Retrospective Clinical Study

Review

Complications of Body Contouring Surgery in Postbariatric Patients: A Systematic Review and Meta-Analysis